Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,5S,8S,11S,14S,17S,20S,22S,23R)-5-[but-2-enyl]-23-hydroxy-14-[(4-hydroxy-3-nitro-phenyl)methyl]-2,11-diisobutyl-10,17,19,22-tetramethyl-8-[[1-[1-methyl-1-(oxiran-2-yl)ethyl]indol-3-yl]methyl]-1,4,7,10,13,16,19-heptazabicyclo[18.3.1]tetracosane-3,6,9,12,15,18,24-heptone
ID: ALA5273454
Max Phase: Preclinical
Molecular Formula: C54H75N9O12
Molecular Weight: 1042.24
Associated Items: